We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Same-Day Coronary Stenting via Wrist

By HospiMedica staff writers
Posted on 29 Nov 2005
The wrist may be a safer port of entry than the groin for coronary-artery stenting and would allow same-day discharge following angioplasty, according to a new study presented at the annual meeting of the American Heart Association in Dallas (TX, USA) in November 2005.

Doctors used transradial percutaneous coronary intervention (PCI) combined with a single bolus administration of RepPro (abciximab) in the study, which allowed patients to be discharged without an overnight stay, according to Olivier Bertrand, M.D., of Laval Hospital (Quebec City, Canada). More...
The study compared 504 patients randomized to same-day discharge with 501 patients randomized to overnight stay.

The results showed that 88% of the patients randomized to same-day procedures were discharged on the same day. Also in the same-day group, 13.9% of patients met the primary endpoint vs 11.8% in the overnight group. Six months later, the rate of death, heart attack, or revascularization was 5.7% in the same-day group and 5.4% in the overnight group. Transradial stenting is also less expensive than groin stenting since it reduces hospital costs and requires only a single bolus of ReoPro.

Although the transradial approach is popular in Canada, few U.S. centers have made the change from the femoral artery to the radial artery. "The radial artery is trickier mainly because of concerns about circulation problems in the hand,” noted Dr. Timothy Gardner, M.D., program chairman of the American Heart Association. "Diabetic patients, for instance, could be problematic.” On the positive side, Dr. Gardner agreed that it is easier to control bleeding with a transradial approach, since it is easy to immobilize the arm and get patients up and walking.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.